Drugs / Vaqta Injectable Product
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03855176 | Sep 2017 → Dec 2022 | HIV infectious disease, hepatitis A virus infection | National Taiwan University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vaqta Injectable Product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03855176 ↗ |
| Modality | Vaccine | “Inactive vaccine against hepatitis A virus” NCT03855176 ↗ |